Bicara Therapeutics Inc. Common Stock (BCAX)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
BCAX Insider Trading Activity
BCAX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $33,624,000 | 2 | 67 |
Sells | $1,021,211 | 1 | 33 |
Related Transactions
| RA CAPITAL MANAGEMENT, L.P. | 1 | $32.99M | 0 | $0 | $32.99M | |
| Flynn James E | Possible Members of 10% Group | 1 | $630,000 | 0 | $0 | $630,000 |
| Meisner Lara | Chief Legal Officer | 0 | $0 | 1 | $1.02M | $-1.02M |
About Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
Insider Activity of Bicara Therapeutics Inc. Common Stock
Over the last 12 months, insiders at Bicara Therapeutics Inc. Common Stock have bought $33.62M and sold $1.02M worth of Bicara Therapeutics Inc. Common Stock stock.
On average, over the past 5 years, insiders at Bicara Therapeutics Inc. Common Stock have bought $33.62M and sold $1.02M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $32.99M. Flynn James E (Possible Members of 10% Group) — $630,000.
The last purchase of 35,000 shares for transaction amount of $630,000 was made by Flynn James E (Possible Members of 10% Group) on 2024‑09‑17.
List of Insider Buy and Sell Transactions, Bicara Therapeutics Inc. Common Stock
| 2025-03-14 | Sale | Meisner Lara | Chief Legal Officer | 79,146 0.1511% | $12.90 | $1.02M | +5.39% | |
| 2024-09-17 | Flynn James E | Possible Members of 10% Group | 35,000 0.045% | $18.00 | $630,000 | -35.65% | ||
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. | 1.83M 2.6517% | $18.00 | $32.99M | -31.29% |
BCAX Institutional Investors: Active Positions
| Increased Positions | 61 | +82.43% | 14M | +37.82% |
| Decreased Positions | 30 | -40.54% | 3M | -8.53% |
| New Positions | 38 | New | 8M | New |
| Sold Out Positions | 23 | Sold Out | 2M | Sold Out |
| Total Postitions | 105 | +41.89% | 47M | +29.29% |
BCAX Ownership Change vs Market
Institutional Investor Ownership
| Ra Capital Management, L.P. | $93,210.00 | 12.88% | 6.96M | 0 | 0% | 2024-12-31 |
| Siren, L.L.C. | $43,856.00 | 6.06% | 3.27M | +200,000 | +6.51% | 2024-12-31 |
| Red Tree Management, Llc | $42,485.00 | 5.87% | 3.17M | +3M | New | 2024-12-31 |
| Tpg Gp A, Llc | $40,340.00 | 5.58% | 3.01M | 0 | 0% | 2024-12-31 |
| Omega Fund Management, Llc | $29,542.00 | 4.08% | 2.2M | 0 | 0% | 2024-12-31 |
| Adage Capital Partners Gp, L.L.C. | $29,149.00 | 4.03% | 2.18M | +1M | +171.91% | 2024-12-31 |
| Fmr Llc | $28,369.00 | 3.92% | 2.12M | -156,704 | -6.89% | 2024-12-31 |
| Braidwell Lp | $26,809.00 | 3.71% | 2M | +343,059 | +20.7% | 2024-12-31 |
| Deep Track Capital, Lp | $26,800.00 | 3.7% | 2M | +1M | +150.99% | 2024-12-31 |
| Deerfield Management Company, L.P. (Series C) | $24,055.00 | 3.32% | 1.8M | 0 | 0% | 2024-12-31 |